Related articles

• Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets
  DOI: 10.7555/JBR.38.20240387
• Anlotinib reverses osimertinib resistance via inhibiting epithelial-to-mesenchymal transition and angiogenesis in non-small cell lung cancer
  DOI: 10.7555/JBR.38.20240045
• hucMSC-derived exosomes protect ovarian reserve and restore ovarian function in cisplatin treated mice
  2023, 37(5): 382-393. DOI: 10.7555/JBR.36.20220166
• Paclitaxel-induced stress granules increase LINE-1 mRNA stability to promote drug resistance in breast cancer cells
  2021, 35(6): 411-424. DOI: 10.7555/JBR.35.20210105
• Postprandial dyslipidemia in insulin resistant states in adolescent populations
  2020, 34(5): 328-342. DOI: 10.7555/JBR.34.20190094
• miR-3622b-5p regulates cisplatin resistance of human gastric cancer cell line by targeting BIRC5
  2019, 33(6): 382-390. DOI: 10.7555/JBR.33.20180078
• Novel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cells
  2016, 30(3): 217-224. DOI: 10.7555/JBR.30.2016K0005
• STAT3 mediates resistance of CD44+CD24-/low breast cancer stem cells to tamoxifen in vitro
  2012, 26(5): 325-335. DOI: 10.7555/JBR.26.20110050
• Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells
  2010, 24(6): 424-435. DOI: 10.1016/S1674-8301(10)60057-7
• The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles
  2010, 24(1): 26-32.